Author

Adam Green

Hebrew University of JerusalemPrimary ORCID profile (0000-0003-2562-746X · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Adam GreeniD1 paper · Morgan Adams Foundation

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Assay:GWAS summary statistics· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Daniel BackenrothiD· 1 shared Einat Granot‐HershkovitziD· 1 shared Judy H. ChoiD· 1 shared Kyle GettleriD· 1 shared Omer WeissbrodiD· 1 shared Or ZukiD· 1 shared Shai CarmiiD· 1 shared Todd LencziD· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetics

Daniel BackenrothORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Utility of polygenic embryo screening for disease depends on the selection strategy

Todd Lencz, Daniel Backenroth, Einat Granot‐Hershkovitz, Adam Green, Kyle Gettler, Judy H. Cho, Omer Weissbrod, Or Zuk, Shai Carmi

This paper predicts the utility of polygenic embryo screening for disease based on selection strategies and finds that selecting the lowest PRS embryo can significantly reduce disease risk.

eLife · Oct 11, 2021Peer-reviewedGenetics